No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MGNX Macrogenics
- 16.680
- -0.260-1.53%
Close Apr 16 16:00 ET
- 16.500
- -0.180-1.08%
Post 18:20 ET
1.04BMarket Cap-111200P/E (TTM)
17.240High16.620Low628.46KVolume16.860Open16.940Pre Close10.61MTurnover1.20%Turnover RatioLossP/E (Static)62.56MShares21.88052wk High6.84P/B871.98MFloat Cap4.29052wk Low--Dividend TTM52.28MShs Float41.000Historical High--Div YieldTTM3.66%Amplitude2.130Historical Low16.882Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Companies Like MacroGenics (NASDAQ:MGNX) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, MacroGenics (NASDAQ:MGNX) has seen its share price rise 157% over the last year, delighting ma
Analysts' Opinions Are Mixed on These Healthcare Stocks: Enlivex (ENLV), MacroGenics (MGNX) and Immuneering (IMRX)
Buy Rating Affirmed for MacroGenics With Promising Vobra Duo Data and Anticipated 2024 Clarifications
Macrogenics Raised to Buy From Hold by TD Cowen
Macrogenics Raised to Buy From Hold by TD Cowen
TD Cowen: Upgraded the Macrogenics (MGNX.US) rating from holding to buying.
TD Cowen: Upgraded the Macrogenics (MGNX.US) rating from holding to buying.
TD Cowen Upgrades Macrogenics to Buy
TD Cowen analyst Boris Peaker upgrades Macrogenics from Hold to Buy.
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg